Global Pharmaceutical Market Drives Innovative Digitalization to Accelerate Drug Discovery

Frost & Sullivan's recent analysis, Global Pharmaceuticals Outlook, finds that the accelerated drug development timelines are driving digitalizati...

 June 17, 2022 | News

Merck Announces Collaboration with Agilent Technologies to Fill Industry Gap in Process Analytical Technologies for Downstream Processing

Merck, a leading science and technology company, today announced that it has entered a collaboration with Agilent Technologies to advance Process Analytica...

 June 16, 2022 | News

Evonik launches new peptide to boost productivity of cell-culture-based biopharmaceuticals

Evonik now offers a highly pure cystine peptide to address challenges in the formulation of cell culture media and processes used in the development and pr...

 June 07, 2022 | News

CStone and Pfizer announce NMPA approval of sugemalimab in patients with unresectable stage III non-small cell lung cancer

CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on research, development, and commercialization of innovative im...

 June 07, 2022 | News

Made-In-Singapore Cancer Drug ETC-159 Advances In Clinical Trials

A made-in-Singapore cancer drug, ETC-159, has advanced into the dose expansion  portion of its Phase 1B clinical trial. The Phase 1B dose expansion st...

 June 06, 2022 | News

Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies

- Boehringer Ingelheim gains exclusive global rights to a panel of cancer-specific antibodies to enable the development of targeted cancer therapies- These...

 June 03, 2022 | News

Cambrex Acquires Leading EU Stability Storage Company Q1 Scientific

"Stability storage and testing is a critical component of drug development and commercialization of new therapies. Q1 Scientific brings world-class capabil...

 June 02, 2022 | News

United BioPharma Receives TFDA Approval for Phase 2 IND for UB-221 to Treat Chronic Spontaneous Urticaria

This Phase 2 clinical trial (double-blind, placebo-controlled) aims to evaluate the efficacy of UB-221 as a long-acting add-on therapy for treatment of chr...

 May 31, 2022 | News

Medison Pharma strengthening its commercial offering into Australia and New Zealand

 Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in international mark...

 May 24, 2022 | News

Croda announces the new Pharma business

Croda Pharma has seen exceptional growth across its high purity excipients and vaccine adjuvants area and more recently announced the acquisition of Avanti...

 May 19, 2022 | News

BD and Mitsubishi Gas Chemical Have Signed a Letter Of Intent (LOI) to Discuss a Partnership Agreement to Explore New Ways to Advance Biologic Drug Delivery

 BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Mitsubishi Gas Chemical Company, Inc. ...

 May 18, 2022 | News

Antengene Announces Addition of Multiple XPOVIO® Treatment Regimens for Myeloma and Lymphoma in 2022 CSCO Guidelines

The 2022 CSCO Guidelines incorporate a total of four selinexor combination therapy regimens for relapsed myeloma. In addition, the guidelines also recommen...

 May 13, 2022 | News

Avantor® and Cytovance Biologics Collaborate to Accelerate Plasmid DNA Development for Biopharma Customers

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies an...

 May 11, 2022 | News

TIKOMED and IQVIA announce a strategic collaboration

Swedish biopharmaceutical company TikoMed AB and IQVIA announce a key strategic collaboration with the aim to accelerate the development of TikoMed's lead ...

 May 06, 2022 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in